Bristol Myers Squibb to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Rhea-AI Summary

Bristol Myers Squibb (NYSE: BMY) announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference. CEO and Board Chair Christopher Boerner, Ph.D., will partake in a fireside chat on June 11, 2024, starting at 11:20 a.m. ET. Investors and the public can listen via a live webcast accessible through the company's investor relations website. An archived version will be available post-event.

Positive

• Participation in a high-profile healthcare conference can enhance visibility and investor confidence.
• CEO Christopher Boerner’s involvement suggests strategic insights and future plans will be discussed.
• Availability of live and archived webcasts increases transparency and accessibility for investors.

Negative

• No specific financial or clinical data updates provided in the announcement.
• Participation in conferences doesn't guarantee positive stock performance or significant business developments.

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Goldman Sachs 45^th Annual Global Healthcare Conference.

Christopher Boerner, Ph.D., Board Chair and Chief Executive Officer, will take part in a fireside chat on Tuesday, June 11, 2024. He will answer questions about the company beginning at 11:20 a.m. ET.

Investors and the general public are invited to listen to a live webcast of the session by visiting http://investor.bms.com. An archived edition of the session will be available following its conclusion.

About Bristol Myers Squibb Company

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

View source version on businesswire.com: https://www.businesswire.com/news/home/20240604456010/en/

Media:

media@bms.com



Investors:

investor.relations@bms.com

Source: Bristol Myers Squibb

FAQ

When will Bristol Myers Squibb participate in the Goldman Sachs Healthcare Conference?

Bristol Myers Squibb will participate on June 11, 2024.

Who will represent Bristol Myers Squibb at the Goldman Sachs Healthcare Conference?

CEO and Board Chair Christopher Boerner, Ph.D., will represent Bristol Myers Squibb.

What time is the Bristol Myers Squibb session at the Goldman Sachs Healthcare Conference?

The session will begin at 11:20 a.m. ET.

How can I listen to the Bristol Myers Squibb session at the Goldman Sachs Healthcare Conference?

You can listen to a live webcast available on the company's investor relations website.

Will there be an archived version of Bristol Myers Squibb's session at the Goldman Sachs Healthcare Conference?

Yes, an archived version will be available following the session.